These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 17284719)

  • 41. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
    Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
    Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats.
    You JF; Buhard O; Ligtenberg MJ; Kets CM; Niessen RC; Hofstra RM; Wagner A; Dinjens WN; Colas C; Lascols O; Collura A; Flejou JF; Duval A; Hamelin R
    Br J Cancer; 2010 Dec; 103(12):1840-5. PubMed ID: 21081928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
    Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
    Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor and Patient Characteristics of Individuals with Mismatch Repair Deficient Colorectal Cancer.
    Waldmann E; Ferlitsch M; Binder N; Sellner F; Karner J; Heinisch B; Klimpfinger M; Trauner M
    Digestion; 2015; 91(4):286-93. PubMed ID: 25924923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability.
    Percesepe A; Kristo P; Aaltonen LA; Ponz de Leon M; de la Chapelle A; Peltomäki P
    Oncogene; 1998 Jul; 17(2):157-63. PubMed ID: 9674699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in defective mismatch repair colon cancer.
    Sargent DJ
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):639-41. PubMed ID: 18827786
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
    Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
    Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients.
    Szybka M; Bartkowiak J; Zakrzewski K; Polis L; Liberski P; Kordek R
    Clin Neuropathol; 2003; 22(4):180-6. PubMed ID: 12908754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
    Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.
    Kuismanen SA; Moisio AL; Schweizer P; Truninger K; Salovaara R; Arola J; Butzow R; Jiricny J; Nyström-Lahti M; Peltomäki P
    Am J Pathol; 2002 Jun; 160(6):1953-8. PubMed ID: 12057899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms underlying mismatch repair deficiencies in normal cells.
    Moliaka YK; Cella M; Chudina AP; Kolesnikova TN; Terracciano L; Cathomas G; Bochkov NP; Buerstedde JM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):305-9. PubMed ID: 9365839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
    Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
    J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
    Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
    Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.